[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353331-105":59,"doc-detail-353331-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","longevity-associated-foxo3-genotype-mitigates-the-risk-of-lung-cancer-after-smoking-cessation-a-prospective-cohort-study","Longevity-associated FOXO3 genotype mitigates the risk of lung cancer after smoking cessation - a prospective cohort study","","Smoking cessation reduces lung cancer risk, yet the benefit varies across individuals. This prospective cohort study evaluated whether the FOXO3 rs2802292 genotype modifies the association between smoking cessation and incident lung cancer, including non-small cell lung cancer. Among 4,339 ever-smoking men of Japanese ancestry, former smokers carrying the longevity-associated FOXO3-G allele showed lower risk than FOXO3-TT carriers, with increasing cessation duration linked to further risk reduction, whereas no genotype differences emerged among current smokers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/longevity-associated-foxo3-genotype-mitigates-the-risk-of-lung-cancer-after-smoking-cessation-a-prospective-cohort-study/353331/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/longevity-associated-foxo3-genotype-mitigates-the-risk-of-lung-cancer-after-smoking-cessation-a-prospective-cohort-study/353331.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study aim regarding FOXO3 genotype and smoking cessation?","Question",{"text":113,"@type":114},"To determine whether the FOXO3 genotype modifies the relationship between smoking cessation and developing incident lung cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants classified by FOXO3 genotype?",{"text":118,"@type":114},"Participants were genotyped for FOXO3 rs2802292 and categorized as FOXO3-G carriers (TG/GG) or FOXO3-TT (TT).",{"name":120,"@type":111,"acceptedAnswer":121},"What main differences were observed between former and current smokers?",{"text":122,"@type":114},"Significant genotype-related differences appeared among former smokers, while no genotype-related differences were observed among current smokers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353331,1790211347,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Original Article  \nLongevity-associated FOXO3 genotype mitigates the risk of lung cancer after smoking cessation: a prospective cohort study  \nRandi Chen 1 ^, Timothy A. Donlon 1,2 ^, Vanessa L. Cunanan 1,3 ^, Kaon Fong 1, Keisuke Miyamoto4, Bradley J. Willcox1,5\\#^, Kamal H. Masaki1,5\\#^  \n1Kuakini Japan-Hawaii Cancer Study, Kuakini Honolulu Heart Program, Center of Biomedical Research Excellence (COBRE) for Clinical and Translational Research on Aging, Department of Research, Kuakini Medical Center, Honolulu, HI, USA; 2Department of Cell and Molecular Biology, University of Hawaii, Honolulu, HI, USA; 3Thompson School of Social Work and Public Health, University of Hawai‘i at Mānoa, Honolulu, HI, USA; 4Department of Internal Medicine, University of Hawaii, Honolulu, HI, USA; 5Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA  \nContributions: (I) Conception and design: R Chen, KH Masaki; (II) Administrative support: KH Masaki; (III) Provision of study materials or patients: R Chen, TA Donlon, K Fong, KH Masaki; (IV) Collection and assembly of data: R Chen, TA Donlon, KH Masaki, BJ Willcox; (V) Data analysis and interpretation: R Chen, TA Donlon, VL Cunanan; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work as the last authors.  \nCorrespondence to: Randi Chen, MS. Kuakini Japan-Hawaii Cancer Study, Kuakini Honolulu Heart Program, Center of Biomedical Research Excellence (COBRE) for Clinical and Translational Research on Aging, Department of Research, Kuakini Medical Center, 347 North Kuakini Street, HPM-8, Honolulu, HI 96817, USA. Email: [r.chen@kuakini.org](r.chen@kuakini.org).  \nBackground: Smoking cessation lowers lung cancer (LC) risk, but the magnitude of risk reduction varies across individuals. FOXO3, a key regulator of cellular stress-response and longevity pathways, may influence susceptibility to LC after smoking cessation. The aim of the present study was to investigate whether FOXO3 genotype modifies  \nthe association between smoking cessation and incident LC.  \nMethods: We examined 4,339 ever-smoking American men of Japanese ancestry who were free of LC at baseline in the Kuakini Japan-Hawaii Cancer Study (1971–1975; mean age, 60 years) . Participants were genotyped for FOXO3 rs2802292 and classified as FOXO3-G (TG/GG; longevity-associated G-allele carriers) or FOXO3-TT (TT, common allele homozygotes) . Smoking status (former or current), cumulative exposure (pack-years), and duration of smoking cessation (years; current smokers assigned 0) were assessed. Incident LC cases through 1999 were identified. Cox proportional hazards models adjusted for potential confounders were used to estimate hazard ratios  \n(HRs) and 95% confidence intervals (CIs), and test interactions.  \nResults: During 28 years of follow-up, 180 LC cases occurred, including 117 non–small cell lung cancer (NSCLC) cases. Significant interactions were observed between smoking status and FOXO3 genotype for LC (P=0.02) and NSCLC (P=0.003) . Among former smokers, FOXO3-G carriers had a lower risk than FOXO3-TT carriers (LC:  \nHR, 0.42; 95% CI, 0.23–0.79; NSCLC: HR, 0.23; 95% CI, 0.09–0.60). In contrast, no genotype-related differences were observed among current smokers. Among FOXO3-G carriers, each additional year of smoking cessation was associated with a reduced risk of LC (HR, 0.87; 95% CI, 0.81–0.94) and NSCLC (HR, 0.72; 95% CI, 0.58–0.89), whereas only weaker associations were observed among FOXO3-TT carriers (LC: HR, 0.97; 95% CI, 0.94–1.00;  \nNSCLC: HR, 0.98; 95% CI, 0.94–1.01) .  \nConclusions: FOXO3 genotype may modify LC risk associated with smoking cessation. Compared with carriers of the longevity-associated FOXO3 G allele, individuals with the FOXO3-TT genotype had a substantially elevated risk of LC after smoking cessation; this association was not observed among current smokers. These findings s","cbCaieADqXauRc06","https://ap.wps.com/l/cbCaieADqXauRc06","pdf",519446,15,"English","# Background\n## Smoking cessation and lung cancer risk\n# Methods\n## Cohort, genotyping, and outcomes\n# Results\n## Interaction effects and risk estimates\n# Conclusions\n## Precision prevention implications","[{\"question\":\"What was the study aim regarding FOXO3 genotype and smoking cessation?\",\"answer\":\"To determine whether the FOXO3 genotype modifies the relationship between smoking cessation and developing incident lung cancer.\"},{\"question\":\"How were participants classified by FOXO3 genotype?\",\"answer\":\"Participants were genotyped for FOXO3 rs2802292 and categorized as FOXO3-G carriers (TG/GG) or FOXO3-TT (TT).\"},{\"question\":\"What main differences were observed between former and current smokers?\",\"answer\":\"Significant genotype-related differences appeared among former smokers, while no genotype-related differences were observed among current smokers.\"}]","Longevity-associated FOXO3 genotype mitigates the risk of lung cancer after smoking cessation - a prospective cohort study | PDF",1790104772,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38c747af06725eee6a06eb6639af6cc0.webp",983,1287,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c6fe49a2261a2bed519af1b70cea601.webp",982,1286,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ff45051ccce39c03083aba02c2f4b96.webp",981,1284,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd92c1737ff8b3621619e656c9d0dc99.webp",980,1283]